415 related articles for article (PubMed ID: 26925708)
1. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B
Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338
[TBL] [Abstract][Full Text] [Related]
3. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer.
Christensen MV; Høgdall C; Jensen SG; Lokman N; Ricciardelli C; Christensen IJ; Christiansen P; Brask J; Karlsen MA; Nissen TK; Jochumsen KM; Høgdall E
Anticancer Res; 2019 May; 39(5):2475-2482. PubMed ID: 31092442
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.
Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C
J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740
[TBL] [Abstract][Full Text] [Related]
5. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Noye TM; Lokman NA; Oehler MK; Ricciardelli C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
7. Multiple functions of S100A10, an important cancer promoter.
Saiki Y; Horii A
Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S
Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862
[TBL] [Abstract][Full Text] [Related]
9. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
[TBL] [Abstract][Full Text] [Related]
10. Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
Gong W; Liu Y; Seidl C; Dreyer T; Drecoll E; Kotzsch M; Bronger H; Dorn J; Magdolen V
PLoS One; 2019; 14(2):e0212968. PubMed ID: 30811511
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
[TBL] [Abstract][Full Text] [Related]
12. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
[TBL] [Abstract][Full Text] [Related]
13. Annexin A2 and S100A10 in the mammalian oviduct.
Teijeiro JM; Roldán ML; Marini PE
Cell Tissue Res; 2016 Feb; 363(2):567-77. PubMed ID: 26329302
[TBL] [Abstract][Full Text] [Related]
14. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
[TBL] [Abstract][Full Text] [Related]
15. Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.
Dettmar L; Ahmed N; Kotzsch M; Diersch S; Napieralski R; Darmoul D; Schmitt M; Weichert W; Kiechle M; Dorn J; Magdolen V
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1109-1118. PubMed ID: 29546479
[TBL] [Abstract][Full Text] [Related]
16. Annexin A2-S100A10 Represents the Regulatory Component of Maxi-Cl Channel Dependent on Protein Tyrosine Dephosphorylation and Intracellular Ca²⁺.
Islam MR; Okada T; Merzlyak PG; Toychiev AH; Ando-Akatsuka Y; Sabirov RZ; Okada Y
Cell Physiol Biochem; 2020 May; 54(4):538-555. PubMed ID: 32442363
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cells.
Inokuchi J; Narula N; Yee DS; Skarecky DW; Lau A; Ornstein DK; Tyson DR
Int J Cancer; 2009 Jan; 124(1):68-74. PubMed ID: 18924133
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis.
Lokman NA; Elder AS; Ween MP; Pyragius CE; Hoffmann P; Oehler MK; Ricciardelli C
Oncotarget; 2013 Aug; 4(8):1199-211. PubMed ID: 23945256
[TBL] [Abstract][Full Text] [Related]
19. N-terminal acetylation of annexin A2 is required for S100A10 binding.
Nazmi AR; Ozorowski G; Pejic M; Whitelegge JP; Gerke V; Luecke H
Biol Chem; 2012 Oct; 393(10):1141-50. PubMed ID: 23091277
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary.
Choi CH; Sung CO; Kim HJ; Lee YY; Song SY; Song T; Kim J; Kim TJ; Lee JW; Bae DS; Kim BG
Hum Pathol; 2013 Jun; 44(6):1017-23. PubMed ID: 23290009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
